Cargando…
Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis
Purpose: To investigate the value-to-value relationships, relationship between values and patient background, continuation rate of treatment after shared decision-making (SDM), and disease status in order to clarify the values involved in drug therapy decisions for patients with rheumatic disease. M...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990622/ https://www.ncbi.nlm.nih.gov/pubmed/36942300 http://dx.doi.org/10.3389/jpps.2023.11135 |
_version_ | 1784901973773910016 |
---|---|
author | Hirata, Ikkou Hanaoka, Shunsuke Rokutanda, Ryo Funakoshi, Ryohkan Hayashi, Hiroyuki |
author_facet | Hirata, Ikkou Hanaoka, Shunsuke Rokutanda, Ryo Funakoshi, Ryohkan Hayashi, Hiroyuki |
author_sort | Hirata, Ikkou |
collection | PubMed |
description | Purpose: To investigate the value-to-value relationships, relationship between values and patient background, continuation rate of treatment after shared decision-making (SDM), and disease status in order to clarify the values involved in drug therapy decisions for patients with rheumatic disease. Methods: We investigated patient values (efficacy of drug therapy [effectiveness], safety, economics, daily life, and other) and the continuance rate and disease status of treatment after 6 months in 94 patients with rheumatic disease aged ≥18 years who made decisions with pharmacists and physicians in the pharmacy outpatient clinic between September 2019 and April 2021. Multiple correspondence and K-means cluster analyses were performed to show the relationship between values and basic patient information. Results: Among the selected patients, 87% and 47% selected effectiveness for multiple selections and single selection, respectively. Effectiveness was at the center of the graph; three clusters containing other values were placed around it. History of allergy or side effects caused by biologics or Janus kinase inhibitors were in the safety cluster. The non-usage history of biologics or Janus kinase inhibitors was in the economic cluster. Conclusion: Effectiveness was the most important factor for patients with rheumatic disease; the values that patients consider important may shift from effectiveness to other values based on each patient’s subjective experience with the treatment and/or the stage of life in which they were treated. It is important to positively link patient values and information about the treatment plan in shared decision-making while establishing rapport with the patient. |
format | Online Article Text |
id | pubmed-9990622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99906222023-03-10 Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis Hirata, Ikkou Hanaoka, Shunsuke Rokutanda, Ryo Funakoshi, Ryohkan Hayashi, Hiroyuki J Pharm Pharm Sci Science archive Purpose: To investigate the value-to-value relationships, relationship between values and patient background, continuation rate of treatment after shared decision-making (SDM), and disease status in order to clarify the values involved in drug therapy decisions for patients with rheumatic disease. Methods: We investigated patient values (efficacy of drug therapy [effectiveness], safety, economics, daily life, and other) and the continuance rate and disease status of treatment after 6 months in 94 patients with rheumatic disease aged ≥18 years who made decisions with pharmacists and physicians in the pharmacy outpatient clinic between September 2019 and April 2021. Multiple correspondence and K-means cluster analyses were performed to show the relationship between values and basic patient information. Results: Among the selected patients, 87% and 47% selected effectiveness for multiple selections and single selection, respectively. Effectiveness was at the center of the graph; three clusters containing other values were placed around it. History of allergy or side effects caused by biologics or Janus kinase inhibitors were in the safety cluster. The non-usage history of biologics or Janus kinase inhibitors was in the economic cluster. Conclusion: Effectiveness was the most important factor for patients with rheumatic disease; the values that patients consider important may shift from effectiveness to other values based on each patient’s subjective experience with the treatment and/or the stage of life in which they were treated. It is important to positively link patient values and information about the treatment plan in shared decision-making while establishing rapport with the patient. Frontiers Media S.A. 2023-01-20 /pmc/articles/PMC9990622/ /pubmed/36942300 http://dx.doi.org/10.3389/jpps.2023.11135 Text en Copyright © 2023 Hirata, Hanaoka, Rokutanda, Funakoshi and Hayashi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Science archive Hirata, Ikkou Hanaoka, Shunsuke Rokutanda, Ryo Funakoshi, Ryohkan Hayashi, Hiroyuki Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis |
title | Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis |
title_full | Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis |
title_fullStr | Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis |
title_full_unstemmed | Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis |
title_short | Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis |
title_sort | shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: a multiple correspondence analysis |
topic | Science archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990622/ https://www.ncbi.nlm.nih.gov/pubmed/36942300 http://dx.doi.org/10.3389/jpps.2023.11135 |
work_keys_str_mv | AT hirataikkou shareddecisionmakingpracticesandpatientvaluesinpharmacistoutpatientcareforrheumaticdiseaseamultiplecorrespondenceanalysis AT hanaokashunsuke shareddecisionmakingpracticesandpatientvaluesinpharmacistoutpatientcareforrheumaticdiseaseamultiplecorrespondenceanalysis AT rokutandaryo shareddecisionmakingpracticesandpatientvaluesinpharmacistoutpatientcareforrheumaticdiseaseamultiplecorrespondenceanalysis AT funakoshiryohkan shareddecisionmakingpracticesandpatientvaluesinpharmacistoutpatientcareforrheumaticdiseaseamultiplecorrespondenceanalysis AT hayashihiroyuki shareddecisionmakingpracticesandpatientvaluesinpharmacistoutpatientcareforrheumaticdiseaseamultiplecorrespondenceanalysis |